DK0386906T3 - Lymfocyt-associeret celleoverfladeprotein - Google Patents

Lymfocyt-associeret celleoverfladeprotein

Info

Publication number
DK0386906T3
DK0386906T3 DK90301884.4T DK90301884T DK0386906T3 DK 0386906 T3 DK0386906 T3 DK 0386906T3 DK 90301884 T DK90301884 T DK 90301884T DK 0386906 T3 DK0386906 T3 DK 0386906T3
Authority
DK
Denmark
Prior art keywords
lymphocyte
lam
cell surface
associated cell
surface protein
Prior art date
Application number
DK90301884.4T
Other languages
Danish (da)
English (en)
Inventor
Thomas F Tedder
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of DK0386906T3 publication Critical patent/DK0386906T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90301884.4T 1989-02-21 1990-02-21 Lymfocyt-associeret celleoverfladeprotein DK0386906T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31310989A 1989-02-21 1989-02-21

Publications (1)

Publication Number Publication Date
DK0386906T3 true DK0386906T3 (da) 1997-10-13

Family

ID=23214421

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90301884.4T DK0386906T3 (da) 1989-02-21 1990-02-21 Lymfocyt-associeret celleoverfladeprotein
DK96112230T DK0770680T3 (da) 1989-02-21 1990-02-21 Antistoffer mod lymfocyt-associeret celleoverfladeprotein

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK96112230T DK0770680T3 (da) 1989-02-21 1990-02-21 Antistoffer mod lymfocyt-associeret celleoverfladeprotein

Country Status (11)

Country Link
US (3) US6020152A (es)
EP (2) EP0386906B1 (es)
JP (3) JP3367661B2 (es)
AT (2) ATE152171T1 (es)
CA (1) CA2010321C (es)
DE (2) DE69034112T2 (es)
DK (2) DK0386906T3 (es)
ES (2) ES2208711T3 (es)
GR (1) GR3024204T3 (es)
HK (2) HK1007331A1 (es)
SG (1) SG43062A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
ATE224444T1 (de) * 1991-06-25 2002-10-15 Dana Farber Cancer Inst Inc Monoklonaler antikörper gegen lymphozytenassoziiertes zelloberflächenprotein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
JP3616090B2 (ja) * 1992-01-27 2005-02-02 イコス コーポレイション 細胞間接着分子関連タンパク質
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5869262A (en) * 1992-01-27 1999-02-09 Icos Corporation Method for monitoring an inflammatory disease state by detecting circulating ICAM-R
US5316920A (en) * 1992-04-17 1994-05-31 Dana-Faber Cancer Institute, Inc. Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
AU2183300A (en) * 1998-12-18 2000-07-12 Incyte Pharmaceuticals, Inc. Lymphocytic membrane proteins
PT1729810T (pt) * 2004-04-02 2018-11-22 Swedish Orphan Biovitrum Ab Publ Métodos de redução da agregação de il-ira

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US4835255A (en) * 1987-03-26 1989-05-30 Yale University T-cell membrane protein
US5389520A (en) * 1989-02-21 1995-02-14 Dana-Farber Cancer Institute, Inc. Specific detection of cell surface receptor leukocyte adhesion molecule-1
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
US5216131A (en) * 1989-02-23 1993-06-01 Genentech, Inc. Lymphocyte homing receptors
US5026537A (en) * 1989-04-06 1991-06-25 Centocor, Inc. Methods for imaging atherosclerotic plaque
US5227369A (en) * 1991-07-11 1993-07-13 The Regents Of The University Of California Compositions and methods for inhibiting leukocyte adhesion to cns myelin
WO1993002698A1 (en) * 1991-07-29 1993-02-18 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies to leukocyte adhesion molecule-1

Also Published As

Publication number Publication date
US5830471A (en) 1998-11-03
JP2001017189A (ja) 2001-01-23
ES2102360T3 (es) 1997-08-01
CA2010321C (en) 2004-04-06
SG43062A1 (en) 1997-10-17
JP2005230016A (ja) 2005-09-02
CA2010321A1 (en) 1990-08-21
HK1011050A1 (en) 1999-07-02
GR3024204T3 (en) 1997-10-31
JPH0322982A (ja) 1991-01-31
DE69034112T2 (de) 2004-07-29
DK0770680T3 (da) 2004-02-23
ATE252637T1 (de) 2003-11-15
EP0386906A1 (en) 1990-09-12
ATE152171T1 (de) 1997-05-15
HK1007331A1 (en) 1999-04-09
EP0770680B1 (en) 2003-10-22
DE69030522D1 (de) 1997-05-28
US6020152A (en) 2000-02-01
EP0386906B1 (en) 1997-04-23
DE69034112D1 (de) 2003-11-27
ES2208711T3 (es) 2004-06-16
DE69030522T2 (de) 1997-12-04
EP0770680A2 (en) 1997-05-02
EP0770680A3 (en) 1997-05-07
JP3367661B2 (ja) 2003-01-14
US6451981B1 (en) 2002-09-17

Similar Documents

Publication Publication Date Title
DE69030522D1 (de) Lymphozyten-assoziiertes Zelloberflächenprotein
DE69027121T2 (de) Bindeligande für tumornekrosisfaktor
SHISHIBA et al. Direct evidence for human thyroidal stimulation by LATS-protector
LU91448I2 (fr) "panitumumab"
FI971406A (fi) TIE-2-ligandeja ja menetelmiä niiden valmistamiseksi ja käyttämiseksi
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
DE68925226D1 (de) Monoklonale Antikörper
NO985904D0 (no) TIE-2-reseptorligander (TIE-ligand-3, TIE-ligand-4), samt anvendelse derav
ATE93730T1 (de) Methode zur erhoehung des wachstums des brustzellgewebes.
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
Amagase et al. Epidermal Growth Factor Prolongs Survival Time of Tumor‐bearing Mice
Leblond et al. Intracellular localization of the precursors of Type I collagen as shown by immunoperoxidasic and immunoradioautographic techniques
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
JPH05194256A (ja) Ｉｌ−６を有効成分として含有する急性期蛋白質誘導剤